JP2018509151A5 - - Google Patents

Download PDF

Info

Publication number
JP2018509151A5
JP2018509151A5 JP2017547412A JP2017547412A JP2018509151A5 JP 2018509151 A5 JP2018509151 A5 JP 2018509151A5 JP 2017547412 A JP2017547412 A JP 2017547412A JP 2017547412 A JP2017547412 A JP 2017547412A JP 2018509151 A5 JP2018509151 A5 JP 2018509151A5
Authority
JP
Japan
Prior art keywords
cell
polypeptide
item
cells
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017547412A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018509151A (ja
JP6775515B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/021693 external-priority patent/WO2016145146A1/en
Publication of JP2018509151A publication Critical patent/JP2018509151A/ja
Publication of JP2018509151A5 publication Critical patent/JP2018509151A5/ja
Priority to JP2020168936A priority Critical patent/JP6970991B2/ja
Application granted granted Critical
Publication of JP6775515B2 publication Critical patent/JP6775515B2/ja
Priority to JP2021173757A priority patent/JP2022025097A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017547412A 2015-03-11 2016-03-10 トランスポザーゼポリペプチド及びその使用 Active JP6775515B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2020168936A JP6970991B2 (ja) 2015-03-11 2020-10-06 トランスポザーゼポリペプチド及びその使用
JP2021173757A JP2022025097A (ja) 2015-03-11 2021-10-25 トランスポザーゼポリペプチド及びその使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562131827P 2015-03-11 2015-03-11
US62/131,827 2015-03-11
PCT/US2016/021693 WO2016145146A1 (en) 2015-03-11 2016-03-10 Transposase polypeptides and uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020168936A Division JP6970991B2 (ja) 2015-03-11 2020-10-06 トランスポザーゼポリペプチド及びその使用

Publications (3)

Publication Number Publication Date
JP2018509151A JP2018509151A (ja) 2018-04-05
JP2018509151A5 true JP2018509151A5 (https=) 2019-04-18
JP6775515B2 JP6775515B2 (ja) 2020-10-28

Family

ID=55587385

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2017547412A Active JP6775515B2 (ja) 2015-03-11 2016-03-10 トランスポザーゼポリペプチド及びその使用
JP2020168936A Active JP6970991B2 (ja) 2015-03-11 2020-10-06 トランスポザーゼポリペプチド及びその使用
JP2021173757A Withdrawn JP2022025097A (ja) 2015-03-11 2021-10-25 トランスポザーゼポリペプチド及びその使用

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2020168936A Active JP6970991B2 (ja) 2015-03-11 2020-10-06 トランスポザーゼポリペプチド及びその使用
JP2021173757A Withdrawn JP2022025097A (ja) 2015-03-11 2021-10-25 トランスポザーゼポリペプチド及びその使用

Country Status (17)

Country Link
US (4) US10570382B2 (https=)
EP (2) EP3268470B1 (https=)
JP (3) JP6775515B2 (https=)
KR (1) KR102615825B1 (https=)
CN (1) CN107532174A (https=)
AU (2) AU2016229094B2 (https=)
CA (1) CA2977818A1 (https=)
DK (1) DK3268470T3 (https=)
ES (1) ES2854675T3 (https=)
HU (1) HUE053368T2 (https=)
IL (2) IL285286B2 (https=)
MX (2) MX388517B (https=)
PL (1) PL3268470T3 (https=)
RU (2) RU2735700C2 (https=)
SG (1) SG11201707111RA (https=)
WO (1) WO2016145146A1 (https=)
ZA (1) ZA201706420B (https=)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10704021B2 (en) 2012-03-15 2020-07-07 Flodesign Sonics, Inc. Acoustic perfusion devices
US10967298B2 (en) 2012-03-15 2021-04-06 Flodesign Sonics, Inc. Driver and control for variable impedence load
US9950282B2 (en) 2012-03-15 2018-04-24 Flodesign Sonics, Inc. Electronic configuration and control for acoustic standing wave generation
US9458450B2 (en) 2012-03-15 2016-10-04 Flodesign Sonics, Inc. Acoustophoretic separation technology using multi-dimensional standing waves
EP3783098A1 (en) 2013-05-14 2021-02-24 Board Of Regents, The University Of Texas System Human application of engineered chimeric antigen receptor (car) t-cells
WO2015105955A1 (en) 2014-01-08 2015-07-16 Flodesign Sonics, Inc. Acoustophoresis device with dual acoustophoretic chamber
EP3656864A1 (en) 2014-02-14 2020-05-27 Board of Regents, The University of Texas System Chimeric antigen receptors and methods of making
CA2964783C (en) 2014-11-05 2024-01-23 Board Of Regents, The University Of Texas System Chimeric antigen receptors (car) to selectively target protein complexes
EP3804741A3 (en) 2015-02-24 2021-07-14 Board of Regents, The University of Texas System Selection methods for genetically-modified t cells
KR102615825B1 (ko) 2015-03-11 2023-12-21 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 전위효소 폴리펩타이드 및 이의 용도
US11377651B2 (en) 2016-10-19 2022-07-05 Flodesign Sonics, Inc. Cell therapy processes utilizing acoustophoresis
US11708572B2 (en) 2015-04-29 2023-07-25 Flodesign Sonics, Inc. Acoustic cell separation techniques and processes
US11021699B2 (en) 2015-04-29 2021-06-01 FioDesign Sonics, Inc. Separation using angled acoustic waves
US11474085B2 (en) 2015-07-28 2022-10-18 Flodesign Sonics, Inc. Expanded bed affinity selection
US11459540B2 (en) 2015-07-28 2022-10-04 Flodesign Sonics, Inc. Expanded bed affinity selection
US10633445B2 (en) 2015-09-15 2020-04-28 Board Of Regents The University Of Texas System T-cell receptor (TCR)-binding antibodies and uses thereof
US11059879B2 (en) 2015-10-27 2021-07-13 Board Of Regents, The University Of Texas System Chimeric antigen receptor molecules and uses thereof
US11085035B2 (en) 2016-05-03 2021-08-10 Flodesign Sonics, Inc. Therapeutic cell washing, concentration, and separation utilizing acoustophoresis
US11214789B2 (en) 2016-05-03 2022-01-04 Flodesign Sonics, Inc. Concentration and washing of particles with acoustics
SG11201810640RA (en) 2016-06-08 2018-12-28 Intrexon Corp Cd33 specific chimeric antigen receptors
CA3041517A1 (en) 2016-10-19 2018-04-26 Flodesign Sonics, Inc. Affinity cell extraction by acoustics
KR20190102259A (ko) 2017-01-10 2019-09-03 인트렉손 코포레이션 신규의 유전자 스위치 발현 시스템을 통한 폴리펩티드의 발현 조절
US11629340B2 (en) 2017-03-03 2023-04-18 Obsidian Therapeutics, Inc. DHFR tunable protein regulation
US11441132B2 (en) * 2017-08-21 2022-09-13 European Molecular Biology Laboratory Mutated sleeping beauty transposase
WO2019118921A1 (en) 2017-12-14 2019-06-20 Flodesign Sonics, Inc. Acoustic transducer drive and controller
IL277128B2 (en) 2018-03-06 2025-11-01 Precigen Inc Hepatitis b vaccines and uses of the same
WO2019173465A1 (en) 2018-03-06 2019-09-12 Intrexon Corporation Human papillomavirus vaccines and uses of the same
WO2020168086A1 (en) * 2019-02-13 2020-08-20 Geerlings Maurits W Nanocarriers for the delivery of nucleic acids and uses thereof
JP7769325B2 (ja) 2019-07-23 2025-11-13 株式会社東芝 Car-t細胞の製造方法、核酸導入キャリア及びキット
CA3150224A1 (en) 2019-09-10 2021-03-18 Obsidian Therapeutics, Inc. Ca2 compositions and methods for tunable regulation
EP4127184A4 (en) * 2020-03-30 2024-04-24 Institute Of Zoology, Chinese Academy Of Sciences ACTIVE DNA TRANSPOSON SYSTEMS AND METHODS OF USE THEREOF
EP4271817A2 (en) 2020-12-30 2023-11-08 Alaunos Therapeutics, Inc. Recombinant vectors comprising polycistronic expression cassettes and methods of use thereof
IL305393A (en) 2021-02-25 2023-10-01 Alaunos Therapeutics Inc Recombinant vectors comprising polycistronic expression cassettes and methods of use thereof
US20250145950A1 (en) 2022-02-01 2025-05-08 Alaunos Therapeutics, Inc. Methods for Activation and Expansion of T Cells
CN118638859A (zh) * 2024-05-10 2024-09-13 中国科学院动物研究所 活性dna转座子系统及其使用方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4554101A (en) 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US4690915A (en) 1985-08-08 1987-09-01 The United States Of America As Represented By The Department Of Health And Human Services Adoptive immunotherapy as a treatment modality in humans
US5925545A (en) * 1996-09-09 1999-07-20 Wisconsin Alumni Research Foundation System for in vitro transposition
US6489458B2 (en) 1997-03-11 2002-12-03 Regents Of The University Of Minnesota DNA-based transposon system for the introduction of nucleic acid into DNA of a cell
WO2000023573A2 (en) 1998-10-20 2000-04-27 City Of Hope Cd20-specific redirected t cells and their use in cellular immunotherapy of cd20+ malignancies
EP1234780A1 (de) * 1999-06-02 2002-08-28 Alcan Technology & Management AG Kindersichere Verpackung für Tabletten
AU2003231048A1 (en) 2002-04-22 2003-11-03 Regents Of The University Of Minnesota Transposon system and methods of use
EP2216342B1 (en) 2003-07-31 2015-04-22 Immunomedics, Inc. Anti-CD19 antibodies
US20060026699A1 (en) * 2004-06-04 2006-02-02 Largaespada David A Methods and compositions for identification of genomic sequences
EP2160461B1 (en) * 2007-07-04 2012-08-08 Max-Delbrück-Centrum für Molekulare Medizin (MDC) Hyperactive variants of the transposase protein of the transposon system sleeping beauty
WO2010008564A2 (en) * 2008-07-16 2010-01-21 Recombinetics Plaice dna transposon system
AU2010206374B2 (en) * 2009-01-23 2013-01-17 Gloriana Therapeutics Sarl Improved cell lines and their use in encapsulated cell biodelivery
KR20140043340A (ko) 2011-04-13 2014-04-09 이뮤니쿰 에이비 T 세포의 프라이밍을 위한 방법
WO2013074916A1 (en) 2011-11-18 2013-05-23 Board Of Regents, The University Of Texas System Car+ t cells genetically modified to eliminate expression of t- cell receptor and/or hla
EP3456734B1 (en) 2012-10-04 2022-01-05 Research Development Foundation Serine protease molecules and therapies
EP3783098A1 (en) 2013-05-14 2021-02-24 Board Of Regents, The University Of Texas System Human application of engineered chimeric antigen receptor (car) t-cells
AU2014268364A1 (en) 2013-05-24 2015-12-10 Board Of Regents, The University Of Texas System Chimeric antigen receptor-targeting monoclonal antibodies
JP2016539929A (ja) 2013-10-25 2016-12-22 ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム 免疫療法のためのポリクローナルγδT細胞
EP3656864A1 (en) 2014-02-14 2020-05-27 Board of Regents, The University of Texas System Chimeric antigen receptors and methods of making
KR20160145802A (ko) 2014-04-23 2016-12-20 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 요법에 사용하기 위한 키메라 항원 수용체 (car) 및 이의 제조 방법
EP3134515B1 (en) 2014-04-24 2019-03-27 Board of Regents, The University of Texas System Application of induced pluripotent stem cells to generate adoptive cell therapy products
CA2964783C (en) 2014-11-05 2024-01-23 Board Of Regents, The University Of Texas System Chimeric antigen receptors (car) to selectively target protein complexes
AU2015343013B2 (en) 2014-11-05 2020-07-16 Board Of Regents, The University Of Texas System Gene modified immune effector cells and engineered cells for expansion of immune effector cells
EP3804741A3 (en) 2015-02-24 2021-07-14 Board of Regents, The University of Texas System Selection methods for genetically-modified t cells
KR102615825B1 (ko) * 2015-03-11 2023-12-21 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 전위효소 폴리펩타이드 및 이의 용도
US10633445B2 (en) 2015-09-15 2020-04-28 Board Of Regents The University Of Texas System T-cell receptor (TCR)-binding antibodies and uses thereof
US11059879B2 (en) 2015-10-27 2021-07-13 Board Of Regents, The University Of Texas System Chimeric antigen receptor molecules and uses thereof

Similar Documents

Publication Publication Date Title
JP2018509151A5 (https=)
Zander et al. Tfh-cell-derived interleukin 21 sustains effector CD8+ T cell responses during chronic viral infection
RU2017134741A (ru) Полипептиды транспозазы и их применение
JP7733865B2 (ja) 強化されたhATファミリーのトランスポゾンが介在する遺伝子導入ならびに関連する組成物、システム、及び方法
CN110730821B (zh) 增强的hAT家族转座子介导的基因转移及相关组合物、系统和方法
Peperzak et al. CD8+ T cells produce the chemokine CXCL10 in response to CD27/CD70 costimulation to promote generation of the CD8+ effector T cell pool
Bolinger et al. Adenoviral vector vaccination induces a conserved program of CD8+ T cell memory differentiation in mouse and man
JP2021518160A5 (https=)
Selich et al. Umbilical cord as a long-term source of activatable mesenchymal stromal cells for immunomodulation
CN107794272A (zh) 一种高特异性的crispr基因组编辑体系
JP2014520551A5 (https=)
CN115698301A (zh) 活性dna转座子系统及其使用方法
JP6022470B2 (ja) 分散型タンパク質形質導入ドメインを含む誘導性発現系転写モジュレータおよびその使用方法
Chakravarti et al. Inducible gene switches with memory in human T cells for cellular immunotherapy
JP7728755B2 (ja) 細胞を再プログラム化して形質細胞様樹状細胞またはi型インターフェロン産生細胞に変換する組成物、その方法および用途
Haertle et al. Identification of the receptor and cellular ortholog of the Marek's disease virus (MDV) CXC chemokine
KR20220105161A (ko) 항원 제시를 위해 세포를 2형 수지상 세포 성분으로 재프로그래밍하기 위한 조성물, 그 방법 및 용도
Serra et al. Engineering of human mesenchymal stem/stromal cells with vascular endothelial growth factor–encoding minicircles for angiogenic ex vivo gene therapy
Kazantseva et al. A mouse model of the Δ133p53 isoform: roles in cancer progression and inflammation
JP2021510080A (ja) T細胞に高い転写活性を有するキメラプロモーター
CN112899238A (zh) 基于RNA-m6A修饰水平的化合物筛选细胞模型及其构建与应用
CN108884443A (zh) 用于重组cxadr表达的组合物和方法
CN104711240B (zh) 禽呼肠孤病毒σA蛋白及其相关生物材料的应用
Kust et al. Functional analysis of Drosophila HSP70 promoter with different HSE numbers in human cells
CN104672317B (zh) 调节Oct4基因表达的转录因子ZNF312b及其应用